Related Experiment Videos
Persistence of haloperidol in human brain tissue
J Kornhuber1, A Schultz, J Wiltfang
1Department of Psychiatry, University of Göttingen, Germany. jkornhu@popper.gwdg.de
The American Journal of Psychiatry
|June 9, 1999
Summary
Haloperidol remains in human brain tissue for weeks after stopping the drug, with a half-life of 6.8 days. This explains prolonged antipsychotic effects and impacts treatment decisions.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Psychiatry
Background:
- Neuroleptic drugs, like haloperidol, exhibit prolonged antipsychotic and antiparkinsonian effects post-discontinuation.
- The cause of these extended effects—persistent drug presence in brain tissue versus long-lasting physiological changes—remains unclear.
Purpose of the Study:
- To directly measure haloperidol concentrations in human brain tissue.
- To investigate the relationship between haloperidol levels in the brain and the duration of drug-free time.
Main Methods:
- Postmortem brain tissue samples from 11 patients treated with haloperidol were analyzed.
- Haloperidol concentrations were quantified in five distinct brain regions using high-performance liquid chromatography with ultraviolet detection.
- Population kinetic analysis was employed to estimate the elimination half-life of haloperidol in brain tissue.
Main Results:
- Haloperidol concentrations in brain tissue were significantly higher (10-30 times) than therapeutic serum levels.
- Brain haloperidol levels were homogeneously distributed within individuals and correlated with higher doses, but not treatment duration.
- The estimated elimination half-life of haloperidol from brain tissue was 6.8 days.
Conclusions:
- Haloperidol persists in human brain tissue for an extended period after drug withdrawal.
- Residual haloperidol effects can last for several weeks, influencing clinical decisions and research protocols.
- Patients should not be considered drug-free for several weeks following haloperidol discontinuation.